Pharmaceuticals
Economy

Almirall raises its profits by 49.4% in the first half of 2026 to 39.6 million

1 min
The facade of the headquarters of the Catalan pharmaceutical company Almirall on Ronda General Mitre in Barcelona, in an archive image.MARC ROVIRA

Almirall closed the first half of 2026 with a net profit of 39.6 million euros, 49.4% more than in the same period of 2025, as reported this Friday to the CNMV. In this period, the pharmaceutical company increased its net sales by 7.5%, to 602.7 million.